PAVMED INC. (NASDAQ:PAVM) Files An 8-K Material Modification to Rights of Security Holders

PAVMED INC. (NASDAQ:PAVM) Files An 8-K Material Modification to Rights of Security Holders
Item 3.03. Material Modification to Rights of Security Holders.

Story continues below

On May 15, 2018, the board of directors of PAVmed, Inc. (“PAVmed”) approved a reduction to the exercise price of PAVmed Inc.’s Series Z warrants (CUSIP number 70387R122) (the “Series Z Warrants”) that trade under the symbol “PAVMZ” on the Nasdaq Capital Market from $3.00 per share to $1.60 per share. Before this reduction takes effect, notice must first be provided to the current holders of Series Z Warrants. The effective date of the exercise price reduction will be June 1, 2018.

PAVmed Inc. issued a press release, filed as Exhibit 99.1, announcing the reduction to the exercise price of the Series Z Warrants.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

Exhibit Description
99.1 Press Release dated May 15, 2018


PAVmed Inc. Exhibit
EX-99.1 2 ex99-1.htm   Exhibit 99.1       PAVMED ANNOUNCES ADJUSTMENT TO SERIES Z WARRANT EXERCISE PRICE   NEW YORK (May 15,…
To view the full exhibit click here

An ad to help with our costs